...
机译:有效性和安全终点的定义中的异质性?对于?克罗恩病的临床试验:a?系统性?回顾
Division of Gastroenterology and Hepatology University of Calgary;
University of Guelph;
St James School of Medicine;
Division of Gastroenterology and Hepatology University of Calgary;
Division of Gastroenterology University of Alberta;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Section of Gastroenterology and Hepatology Dartmouth-Hitchcock Medical Center;
Department of Gastroenterology and Inserm U954 Nancy University Hospital;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Robarts Clinical Trials Western University;
Inflammatory Bowel Disease; IBD; Treatment; Effects; RCT;
机译:有效性和安全终点的定义中的异质性?对于?克罗恩病的临床试验:a?系统性?回顾
机译:阿达木单抗对克罗恩病的疗效和安全性:已发表的随机安慰剂对照试验的系统评价和荟萃分析
机译:阿巴罗单抗对克罗恩病的疗效和安全性:发表随机安慰剂对照试验的系统审查和荟萃分析
机译:癌症临床试验疗效和毒性终点:比较两种非参数方法的仿真研究
机译:在随机对照试验的系统评价中探索异质性的方法。
机译:依泽替米贝在主要心血管终点指标上的临床疗效和安全性:随机对照试验的系统评价和荟萃分析
机译:溃疡性结肠炎临床试验的终点定义中的异质性:核心结果组的发展系统审查